Journal article
Recent advances in the drug treatment of heart failure
Abstract
A number of important questions surrounding the treatment of systolic congestive heart failure have been answered by randomised clinical trials completed within the past 2 years. In particular, these studies have established that high-dose angiotensin-converting enzyme (ACE) inhibition is more beneficial than low dose therapy, and that angiotensin II receptor antagonists are an acceptable alternative in patients unable to tolerate ACE …
Authors
McAlister FA; Teo KK
Journal
Postgraduate Medical Journal, Vol. 74, No. 877, pp. 658–661
Publisher
Oxford University Press (OUP)
Publication Date
November 1, 1998
DOI
10.1136/pgmj.74.877.658
ISSN
0032-5473